Cell and Gene Outsourcing
-
Biopharmaceuticals Development And Manufacturing: Wide-Ranging Expertise And Vertically Integrated Service
11/17/2021
The company’s wide-ranging expertise and vertically integrated service offering translate to the ability to rapidly execute multiple projects from its state-of-the-art cGMP facilities while ensuring full process and product compliance at all stages of research, development and commercial manufacturing.
-
Mitigating Risk Through Product Characterization
7/17/2019
In this webinar, multiple approaches to characterizing the physico-chemical and structural attributes of therapeutic mAbs is presented with a focus on how it influences the resulting biological activity.
-
Effective Supply Chain And QC Testing Through Collaborative Partnerships
9/30/2025
Explore how cross-functional teams streamline cell therapy manufacturing and release for Phase 1 trials to meet patient timelines and ensure safe delivery of personalized treatments.
-
Make More Lentivirus And Make It Right The First Time
6/14/2024
Discover how you can achieve higher titers and robust yield with an optimized, end-to-end lentivirus platform, designed to maximize production and quality for the success of your cell or gene therapy.
-
How Molecular Structure Influences Potency Of A Therapeutic Biologic
7/17/2019
Gain an understanding of how an antibody’s molecular structure and its many measurable properties influences its binding and affects potency of a therapeutic biologic.
-
Explore What's Next: Product Characterization
7/17/2019
Newer, high-resolution analytical techniques help answer questions regarding product heterogeneity and drug functions, and help assess for product-related aggregates and impurities.
-
The Journey To Safety Through Viral Clearance
12/1/2022
Discover a simple yet powerful solution for getting viral clearance studies done safely, thoroughly, efficiently, and on your timelines. Learn how to free your teams and trust your project.
-
How To Boost AAV Titer With Feed Supplementation In Both HEK293 And Sf-9 Platforms
11/25/2024
Explore how optimizing post-transfection or post-infection feeding in HEK293 and Sf-9 cells significantly boosts AAV titers, enhancing production efficiency for gene therapy applications.
-
PEI And Non-PEI Transfection Solutions For High Titers And Production
9/2/2025
Discover optimized AAV production with polyethylenimine (PEI) and non-polyethylenimine transfection solutions that are designed to boost titers and streamline scalability.
-
How MilliporeSigma Promotes Quality And Risk Reduction
10/20/2021
Learn how MilliporeSigma’s new facility was built with quality and risk reduction at the top of mind and its experts have the experience to support large-scale programs through commercialization.